The short answer
Reported activity centres on interference with NF-κB signalling and reduced pro-inflammatory cytokine production. Unlike its parent hormone, KPV's described action is not primarily receptor-mediated. It is small enough to enter cells, which changes what kind of mechanism is plausible.
Key facts
- Reported target
- NF-κB signalling
- Reported effect
- Reduced pro-inflammatory cytokines
- Melanocortin receptor
- Not the primary route described
- Size advantage
- 342 Da (small enough to enter cells)
- Model systems
- Cell culture and murine models
- Human clinical data
- None established
What NF-κB does
NF-κB is a transcription factor and one of the central switches of inflammatory signalling. Held inactive in the cytoplasm under normal conditions, it moves to the nucleus when inflammatory signals arrive and drives transcription of cytokines and other inflammatory mediators. Interfering with it affects a broad set of downstream outputs at once.
Why size changes the mechanism question
Alpha-MSH at 1,665 Da acts at cell-surface melanocortin receptors. It is far too large to cross a membrane passively. KPV at 342 Da is a different proposition entirely. A tripeptide of that size can plausibly enter cells, which permits an intracellular mechanism the parent hormone could not have. That is the most interesting structural consequence of the fragment being so short.
Research material referenced
KPV 10mg, third-party HPLC tested
What the models measured
Kannengiesser and colleagues reported anti-inflammatory potential in murine colitis models in 2008. Cell-culture work has examined cytokine production and NF-κB pathway activity. These establish that the compound does something measurable to inflammatory signalling in those systems, which is a statement about those systems.
Why the delivery paper is informative
Xiao and colleagues published on orally targeted delivery of KPV using hyaluronic acid-functionalised nanoparticles in Molecular Therapy in 2017. Researchers do not build targeted delivery systems for compounds that reach their target unaided. The existence of that work tells you the free tripeptide's own delivery to inflamed tissue was the limiting problem.
What is not established
A defined molecular target. NF-κB interference is a described effect rather than a mapped binding interaction, and no receptor or direct binding partner has been characterised. As with several compounds in this library, the downstream consequences are better documented than the initiating event.
And what is not claimed
Nothing about inflammation in people. The work is cell culture and murine models, there is no established human clinical programme, and KPV holds no marketing authorisation anywhere. Colitis models are disease models, not evidence of a treatment.
Frequently asked questions
Does KPV act on melanocortin receptors?
That is not the primary route described. At 342 Da it is small enough for an intracellular mechanism its 1,665 Da parent hormone could not have.
What is NF-κB?
A transcription factor central to inflammatory signalling, driving cytokine production when activated. Interfering with it affects many downstream outputs at once.
Is there human evidence?
No established clinical programme. The literature is cell culture and murine models.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More KPV articles
- KPV Structure and Physical PropertiesThree residues, 342.43 Da, one proline and one lysine. What a tripeptide can and cannot do structurally, and why analysis is difficult.
- KPV Chemical IdentitySearching PubChem for KPV returns an unrelated organic acid. The peptide is indexed as Lys-Pro-Val, CID 125672, 342.43 Da.
- KPV Storage and HandlingA 342 Da tripeptide with no cysteine or methionine. Chemically robust, but adsorption to surfaces matters more than it does for larger peptides.
- Fragment Logic: KPV Against Its ParentIsolating three residues from a thirteen-residue hormone separates one function from another. What that buys, and what it cannot guarantee.
- What the Colitis Models ReportedKannengiesser 2008 reported anti-inflammatory potential in murine colitis. What a disease model establishes, and the gap before any clinical claim.